NP47822 Multiple Sclerosis Medicines
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £17,031,052 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Scotland |
| Deadline | 1 Dec 2022 |
| Procedure | open |
| OCID | ocds-h6vhtk-037dca |
Awards (4)
This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £17,031,052.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Biogen Idec Ltd shared | · | · | active |
| Merck Serono Limited shared | · | · | · |
| Mylan shared | · | · | active |
| Teva UK Limited shared | · | · | active |
description
Supply of Multiple Sclerosis Medicines to NHS Scotland
documents
- NP47822 Multiple Sclerosis Medicines , awardNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 31 Oct 2022 | Contract notice (F02) | Earlier regulations | 030719-2022 |
| 15 Feb 2023 | Contract award notice (F03) | Earlier regulations | 004666-2023 |
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Public Contracts Scotland. Contact details for named individuals are not reproduced on this site.